Foamix Pharmaceuticals Ltd.
DelistedCIK 1606645fmd_1EW2NK932HYSPR9K95TDDKYMSFManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2019, 22 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 5 | 1 | 6 | 4 | 4 | 0 |
| Cost of revenue | 0 | 0 | 1 | 0 | 0 | 0 | – | – |
| Gross profit | 1 | 1 | 5 | 1 | 5 | 4 | 4 | 0 |
| Research and development | 1 | 1 | 4 | 11 | 26 | 58 | 64 | 51 |
| Selling, general and administrative | 1 | 1 | 3 | 7 | 9 | 11 | 14 | 45 |
| Compensation and benefits | 1 | 1 | 2 | 4 | – | – | – | – |
| Operating income | (2) | (1) | (2) | (17) | (30) | (66) | (75) | (96) |
| Interest expense | – | – | – | – | – | – | – | 1 |
| Income before taxes | – | (2) | (11) | (16) | (29) | (65) | (74) | (95) |
| Income tax expense | – | – | 0 | 0 | 0 | 1 | 0 | (0) |
| Net income from continuing operations | – | – | (11) | (17) | (29) | (66) | (74) | (95) |
| Net income | (2) | (2) | (11) | (17) | (29) | (66) | (74) | (95) |